Skip to content
Screener

Inhibikase Therapeutics, Inc. IKT Q1 2025 Annual earnings

Reported May 14, 2025 · Before market open

EPS-$0.15Miss by $0.04
EPS estimate-$0.11

Next report

Nov 13, 2026 (in 2 months)
EPS estimate-$0.11

FAQ

When did Inhibikase Therapeutics, Inc. report Q1 2025 earnings?
Inhibikase Therapeutics, Inc. (IKT) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Inhibikase Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Inhibikase Therapeutics, Inc. reported eps of $-0.15 for Q1 2025.
Did Inhibikase Therapeutics, Inc. beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.11 by $0.04.
How did Inhibikase Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 79.5% from $-0.73.
Where can I find Inhibikase Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-119939) and the 10-K/A periodic report (0000950170-25-058693) directly on SEC EDGAR. The filing index links above go to sec.gov.